Compositions and methods
US9750794B2 · kind B2 · utility
0Cited by
3References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 11, 2016 |
| Grant date | Sep 5, 2017 |
| Priority date | — |
| Expiry date | Mar 11, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a polypeptide which comprises: (i) an Rv1753c protein sequence; (ii) a variant of an Rv1753c protein sequence; or (iii) an immunogenic fragment of an Rv1753c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.